Zalicus ( ZLCS) is a biopharmaceutical company developing drug candidates with a focus on the treatment of pain and inflammation. This stock is trading up 2.9% to $1.07 in recent trading. Today's Range: $1.08-$1.16 52-Week Range: $0.82-$3.21 Volume: 3.5 million Three-Month Average Volume: 941,213 From a technical perspective, ZLCS is gapping up strong today back above its 50-day moving average of $1.09 on monster volume. Traders should continue to look for long biased trades as long as ZLCS is trending above its 50-day. The next major breakout trade will trigger for ZLCS once the stock takes out some near-term overhead resistance at $1.16 with volume. A sustained high-volume move and close above that level should set this stock up for some decent upside. Some potential upside targets are $1.36 to $1.54.